Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19600446 | 0.89 | KDM4E (0.37) | KDM4EMAPK1ATMAHRKMT2A | |
| SCHEMBL17737554 | 0.88 | MAPK1 (0.36) | KDM4EMAPK1ATMAHRALDH1A1 | |
| SCHEMBL19600411 | 0.87 | MAPK1 (0.35) | KDM4EMAPK1ATMAHRALDH1A1 | |
| SCHEMBL19600436 | 0.86 | KDM4E (0.35) | KDM4EMAPK1ATMAHR | |
| SCHEMBL17737556 | 0.83 | KDM4E (0.31) | KDM4EMAPK1ATM | |
| SCHEMBL17737527 | 0.80 | HSD17B10 (0.38) | KDM4EMAPK1AHRKMT2AALDH1A1 | |
| SCHEMBL17737558 | 0.79 | MAPK1 (0.32) | KDM4EMAPK1ATMALDH1A1HPGD | |
| SCHEMBL17737530 | 0.79 | HSD17B10 (0.43) | KDM4EMAPK1AHRKMT2AALDH1A1 | |
| SCHEMBL27126967 | 0.77 | MAPK1 (0.47) | KDM4EMAPK1ATMAHRALDH1A1 | |
| SCHEMBL17737559 | 0.76 | CYP1A2 (0.39) | KDM4EMAPK1AHRKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10573825-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-25 | — | — | US | disclosed |
| US-20170331051-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-16 | — | — | US | disclosed |
| US-20170331051-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10573825-B2 | Compound and organic light-emitting device including the same | CRY1, CRY2, AOX1 | KDM4E 2074/4885MAPK1 2174/4885ATM 2475/4885 |
| US-20170331051-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, AOX1 | KDM4E 2074/4885MAPK1 2174/4885ATM 2475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.